Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients

Treatment with Tumor Necrosis Factor-α a

Treatment with Tumor Necrosis Factor-α and Granulocyte–Macrophage Colony-Stimulating Factor Increases Epidermal Langerhans' Cell Numbers in Cancer Patients

✍ John E. Janik; Langdon L. Miller; William C. Kopp; Dennis D. Taub; Harry Dawson; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 229 KB

271 Phase II Study of Thalidomide, inter

271 Phase II Study of Thalidomide, interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients with metastatic renal cell carcinoma (RCC)

✍ R. Amato; J. Brown; A. Rawat 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB

In vivo effects of sequential granulocyt

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB–IV melanoma

✍ John L. Zapas; Joanne Hasskamp; Sandra Beam; Sally Brown; E.George Elias 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Fractionated cyclophosphamide, vincristi

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage–colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia

✍ Apostolia M. Tsimberidou; Hagop M. Kantarjian; Jorge Cortes; Deborah A. Thomas; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## BACKGROUND Therapy for patients with Richter syndrome (RS) or fludarabine‐refractory chronic lymphocytic leukemia (CLL) is unsatisfactory. A Phase II study was conducted to evaluate an alternating combination cytotoxic regimen given with rituximab and granulocyte‐macrophage–colony s

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol of a controlled clinical trial developed by consensus of an international study group¶ Part one: rationale and hypothesis

✍ W. Lorenz, B. Stinner, A. Bauhofer, M. Rothmund, I. Celik, A. Fingerhut, M. Koll 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 87 KB

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol of a controlled clinical trial developed by consensus of an international study group¶ Part three: individual patient, complication algorithm and quality management¶

✍ B. Stinner; A. Bauhofer; W. Lorenz; M. Rothmund; U. Plaul; A. Torossian; I. Celi 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 218 KB